Ana Apezteguia

Ana has more than five years of experience in business strategy and project management within the pharmaceutical industry.

She initially joined Neuraxpharm as Strategy Associate to the CEO. She made the step up to Corporate Strategy Manager having played a key role in the successful integration of the Group’s different territories across a number of countries. Ana also leads the strategic development of the cannabidiol (CBD) business in Swiss affiliate S.T.U. GmbH.

She developed her professional career as Senior Business and Strategy Consultant at Capgemini Invent (formerly Capgemini Consulting), mainly working on pharmaceutical industry projects.

Ana holds a bachelor’s degree in Industrial Engineering from the Universitat Politècnica de Catalunya (UPC), specialising in management and industrial organisation, and higher education qualifications in strategy production from École Nationale Supérieure de Techniques Avancées (ENSTA) in Paris.